12:00 AM
May 08, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

89-12: Phase II

AVAN said that results from a second-year extension of its placebo-controlled 215-infant Phase II study showed that of the 184 infants available for the second year of...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >